In addition, compared with the model group, 20 mg/kg of erianin could dramatically restrain the tumor growth of tumor-bearing mice, and significantly reduced the level of MMP-2, -9, and IL-10 in the serum. This evidence concerns the gene IL10 and neoplasm.